Literature DB >> 14576540

Women have the same desflurane minimum alveolar concentration as men: a prospective study.

Anupama Wadhwa1, Jaleel Durrani, Papiya Sengupta, Anthony G Doufas, Daniel I Sessler.   

Abstract

BACKGROUND: Women generally report greater sensitivity to pain than do men, and healthy young women require 20% more anesthetic than healthy age-matched men to prevent movement in response to noxious electrical stimulation. In contrast, minimum alveolar concentration (MAC) for xenon is 26% less in elderly Japanese women than in elderly Japanese men. Whether anesthetic requirement is similar in men and women thus remains in dispute. The authors therefore tested the hypothesis that the desflurane concentration required to prevent movement in response to skin incision (MAC) differs between men and women.
METHODS: Using the Dixon "up and down" method, the authors determined MAC for desflurane in 15 female and 15 male patients (18-40 yr old) undergoing surgery.
RESULTS: MAC was 6.2 +/- 0.4% desflurane for women versus 6.0 +/- 0.3% for men (P = 0.31), a difference of only 3%. These data provide 90% power to detect a 9% difference between the groups.
CONCLUSIONS: The MAC of desflurane did not differ between young men and women undergoing surgery with a true surgical incision. Although pain sensitivity may differ in women versus men, MAC of desflurane does not.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14576540      PMCID: PMC1552095          DOI: 10.1097/00000542-200311000-00010

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  31 in total

1.  Menstrual cycle, blood pressure and ischemic pain sensitivity in women: a preliminary investigation.

Authors:  M Pfleeger; P A Straneva; R B Fillingim; W Maixner; S S Girdler
Journal:  Int J Psychophysiol       Date:  1997-09       Impact factor: 2.997

2.  Effect of age on MAC in humans: a meta-analysis.

Authors:  W W Mapleson
Journal:  Br J Anaesth       Date:  1996-02       Impact factor: 9.166

3.  Reduction of the MAC of desflurane with fentanyl.

Authors:  P S Sebel; P S Glass; J E Fletcher; M R Murphy; C Gallagher; T Quill
Journal:  Anesthesiology       Date:  1992-01       Impact factor: 7.892

Review 4.  Nongenomic actions of estrogen in the brain: physiological significance and cellular mechanisms.

Authors:  M Wong; T L Thompson; R L Moss
Journal:  Crit Rev Neurobiol       Date:  1996

5.  Minimum alveolar concentration of halothane and enflurane are decreased in early pregnancy.

Authors:  M T Chan; P Mainland; T Gin
Journal:  Anesthesiology       Date:  1996-10       Impact factor: 7.892

6.  Gender effects and central opioid analgesia.

Authors:  Karen L Kepler; Kelly M Standifer; Dennis Paul; Benjamin Kest; Gavril W Pasternak; Richard J Bodnar
Journal:  Pain       Date:  1991-04       Impact factor: 6.961

Review 7.  Estrogen: nontranscriptional signaling pathway.

Authors:  R L Moss; Q Gu; M Wong
Journal:  Recent Prog Horm Res       Date:  1997

Review 8.  Desflurane animal and human pharmacology: aspects of kinetics, safety, and MAC.

Authors:  E I Eger
Journal:  Anesth Analg       Date:  1992-10       Impact factor: 5.108

Review 9.  Gender variations in clinical pain experience.

Authors:  A M Unruh
Journal:  Pain       Date:  1996 May-Jun       Impact factor: 6.961

10.  Gender difference in analgesic response to the kappa-opioid pentazocine.

Authors:  R W Gear; N C Gordon; P H Heller; S Paul; C Miaskowski; J D Levine
Journal:  Neurosci Lett       Date:  1996-03-01       Impact factor: 3.046

View more
  10 in total

1.  Modulation of human 5-hydroxytryptamine type 3AB receptors by volatile anesthetics and n-alcohols.

Authors:  Renna Stevens; Dirk Rüsch; Ken Solt; Douglas E Raines; Paul A Davies
Journal:  J Pharmacol Exp Ther       Date:  2005-04-14       Impact factor: 4.030

Review 2.  [Pharmacokinetic-pharmacodynamic models for inhaled anaesthetics].

Authors:  S Kreuer; J Bruhn; W Wilhelm; T Bouillon
Journal:  Anaesthesist       Date:  2007-06       Impact factor: 1.041

Review 3.  Gender-specific differences in the central nervous system's response to anesthesia.

Authors:  Lana J Mawhinney; Davita Mabourakh; Michael C Lewis
Journal:  Transl Stroke Res       Date:  2012-11-29       Impact factor: 6.829

4.  Age-dependent decrease in minimum alveolar concentration of inhaled anaesthetics: a systematic search of published studies and meta-regression analysis.

Authors:  Mary Cooter; Katherine Ni; Jake Thomas; Dhanesh K Gupta; Thomas J Hopkins; Timothy E Miller; Michael L James; Miklos D Kertai; Miles Berger
Journal:  Br J Anaesth       Date:  2019-11-01       Impact factor: 9.166

5.  Reduction of greenhouse gases emission through the use of tiletamine and zolazepam.

Authors:  Sonia Lachowska; Agnieszka Antończyk; Joanna Tunikowska; Martyna Godniak; Zdzisław Kiełbowicz
Journal:  Sci Rep       Date:  2022-06-09       Impact factor: 4.996

6.  Desflurane requirements for laryngeal mask airway insertion during inhalation induction.

Authors:  Hwa-Yong Shin; Jung-Ae Lim; Seong-Hyop Kim; Seung-Woo Baek; Duk-Kyung Kim
Journal:  J Anesth       Date:  2009-05-15       Impact factor: 2.078

7.  Anesthetic requirement is increased in redheads.

Authors:  Edwin B Liem; Chun-Ming Lin; Mohammad-Irfan Suleman; Anthony G Doufas; Ronald G Gregg; Jacqueline M Veauthier; Gary Loyd; Daniel I Sessler
Journal:  Anesthesiology       Date:  2004-08       Impact factor: 7.892

8.  Molecular properties important for inhaled anesthetic action on human 5-HT3A receptors.

Authors:  Renna J N Stevens; Dirk Rüsch; Paul A Davies; Douglas E Raines
Journal:  Anesth Analg       Date:  2005-06       Impact factor: 6.627

9.  Postoperative recovery of patients with differential requirements for sevoflurane after abdominal surgery: A prospective observational clinical study.

Authors:  Jia Li; Yi Yong Wei; Dong Hang Zhang
Journal:  Medicine (Baltimore)       Date:  2021-02-26       Impact factor: 1.817

10.  Duration effect of desflurane anesthesia and its awakening time and arterial concentration in gynecologic patients.

Authors:  Tso-Chou Lin; Chih-Cherng Lu; Che-Hao Hsu; Gwo-Jang Wu; Meei-Shyuan Lee; Shung-Tai Ho
Journal:  Clinics (Sao Paulo)       Date:  2013-10       Impact factor: 2.365

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.